Chairman emeritus Peter C. Farrell - 24 Nov 2025 Form 4 Insider Report for RESMED INC (RMD)

Role: Director
Signature: /s/ Michael J. Rider, attorney-in-fact for Mr. Farrell
Issuer symbol: RMD
Transactions as of: 24 Nov 2025
Net transactions value: +$333,442
Form type: 4
Filing time: 26 Nov 2025, 15:26:53 UTC
Previous filing: 24 Nov 2025
Next filing: 04 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
FARRELL PETER C	Director	9001 SPECTRUM CENTER BLVD., SAN DIEGO	/s/ Michael J. Rider, attorney-in-fact for Mr. Farrell	26 Nov 2025	0001186102

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	RMD	ResMed Common Stock						70,773	24 Nov 2025	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RMD	ResMed Common Stock Options	Award	$333,442	+1,331		$250.52	1,331	24 Nov 2025	ResMed Common Stock	1,331	$250.52	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the date on which options first become exercisable. The options vest on the earlier of (i) November 11, 2026, or (ii) the date of the first annual meeting of stockholders of the Company following the Grant Date.